Skip to main content
. 2021 Apr 14;16:179. doi: 10.1186/s13023-021-01775-8

Table 1.

Main findings in the 9 Chinese patients and our case

Reference Total cases Sex, Age onset ZFYVE19 gene mutations First clinical features Clinical evolution Hystopathologic features Renal cystic change ↑GGT
↑GPT
↑GOT
Outcome Ciliary studies
Nucleotide change Aminoacid change
Luan et al. (2020) 9 M, birth c.314C > G p.S105X Neonatal jaundice Resolved Jaundice, 8 months. Hepato-splenomegaly. UGIH Explanted liver, micronodular cirrhosis, ductular reaction No Yes LT at 5 y 6 m

In ZFYVE19-knockdown hRPE1 cells, a prominent phenotypical abnormality, was an increase in numbers of basal bodies/centrioles. Separation/abnormal arrangement of the centriole pair(s) was also observed. However, cilium assembly was not affected and extra cilia took shape at extra basal bodies/ centrioles

In ZFYVE19-deficient fibroblast-like cells derived from patient iPSCs, similar phenotypes involving abnormalities of ciliary and centriolar numbers but not of cilium assembly

were demonstrated

In both cells: supernumerary centrioles and cilia when ZFYVE19 was depleted

Sisters F, 5 y

c.226A > G

c.314C > G

p.M76V

p.S105X

Hepato-splenomegaly. Portal hypertension DPM No Yes Improved LFTs on UDCA at 15 y worsened on UDCA at 17 y
F, 14 m Hepatomegaly Hepatomegaly No Yes Improved LFTs on UDCA at 10 y 4 m; UDCA stopped at 12 y 4 m
M, 40 days

c.314C > G

c.514C > T

p.S105X p.R172X Neonatal jaundice, diarrhoea Pruritus. Hepato-splenomegaly. Portal hypertension DPM No Yes Improved LFTs on UDCA at 14 y 1 m
M, 4 m c.314C > G p.S105X Fever, diarrhea Hepato-splenomegaly. Portal hypertension. UGIH DPM, cholestasis No Yes LT at 6 y 4 m
M, 3 m c.547C > T c.314C > G p.R183X p.S105X Neonatal jaundice Hepato-splenomegaly Portal widening and fibrosis, ductular reaction No Yes Normalised LFTs on UDCA at 6 y
Sisters F, 9 y c.514C > T p.R172X Hepato-splenomegaly Hepato-splenomegaly DPM No Yes Improved LFTs on UDCA at 11 y
F, 4 y UGIH

DPM, fibro-obliterative

loss of bile ducts with DPM

No Yes LT at 4 y 8 m
M, 3 m c.379C > T c.314C > G p.Q127X p.S105X

Neonatal jaundice

Fever, cough

Hepato-splenomegaly. Portal hypertension. UGIH

DPM, fibro-obliterative

loss of bile ducts with DPM, cholestasis

No Yes LT at 1 y 10 m
Present case 1 F, 59 days c.667C > T

p.R223X

[p.Arg223Ter]

Cholestatic jaundice. Hepato-splenomegaly

Hepato-splenomegaly

Anicteric cholestasis

Micronodular cirrhosis, bile ducts proliferation and portal tract abnormalities consonant with DPM or CHF No Yes Mild ↑ LFTs, persistent anicteric cholestasis with preserved protein synthesis, on UDCA and Rifampicin (5y) Immunofluorescence analysis of primary cilia on cultured skin fibroblasts showed fragmented cilia and centrioles abnormalities

DPM, ductal plate malformation; GGT, serum Gamma glutamyl tranpeptidase; GOT, serum glutamic oxaloacetic transaminase; GPT, serum glutamic pyruvic transaminase; LFT, liver function test; LT, liver transplantation; UDCA, ursodeoxycholic acid; UGIH, recurrent upper gastrointestinal haemorrhage; y, year; m, month; , increased